Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction

NCT03274752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Remodeling
Myocardial Infarction

Interventions

DRUG: Paroxetine
DRUG: Placebo oral capsule

Sponsor

Insel Gruppe AG, University Hospital Bern